156 related articles for article (PubMed ID: 25345847)
1. The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' disease.
Kuś A; Szymański K; Peeters RP; Miśkiewicz P; Porcu E; Pistis G; Sanna S; Naitza S; Płoski R; Medici M; Bednarczuk T
Clin Endocrinol (Oxf); 2015 Oct; 83(4):556-62. PubMed ID: 25345847
[TBL] [Abstract][Full Text] [Related]
2. Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.
Kuś A; Szymański K; Jurecka-Lubieniecka B; Pawlak-Adamska E; Kula D; Miśkiewicz P; Bolanowski M; Płoski R; Bossowski A; Daroszewski J; Jarząb B; Bednarczuk T
J Hum Genet; 2017 Mar; 62(3):373-377. PubMed ID: 27829681
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.
Medici M; Porcu E; Pistis G; Teumer A; Brown SJ; Jensen RA; Rawal R; Roef GL; Plantinga TS; Vermeulen SH; Lahti J; Simmonds MJ; Husemoen LL; Freathy RM; Shields BM; Pietzner D; Nagy R; Broer L; Chaker L; Korevaar TI; Plia MG; Sala C; Völker U; Richards JB; Sweep FC; Gieger C; Corre T; Kajantie E; Thuesen B; Taes YE; Visser WE; Hattersley AT; Kratzsch J; Hamilton A; Li W; Homuth G; Lobina M; Mariotti S; Soranzo N; Cocca M; Nauck M; Spielhagen C; Ross A; Arnold A; van de Bunt M; Liyanarachchi S; Heier M; Grabe HJ; Masciullo C; Galesloot TE; Lim EM; Reischl E; Leedman PJ; Lai S; Delitala A; Bremner AP; Philips DI; Beilby JP; Mulas A; Vocale M; Abecasis G; Forsen T; James A; Widen E; Hui J; Prokisch H; Rietzschel EE; Palotie A; Feddema P; Fletcher SJ; Schramm K; Rotter JI; Kluttig A; Radke D; Traglia M; Surdulescu GL; He H; Franklyn JA; Tiller D; Vaidya B; de Meyer T; Jørgensen T; Eriksson JG; O'Leary PC; Wichmann E; Hermus AR; Psaty BM; Ittermann T; Hofman A; Bosi E; Schlessinger D; Wallaschofski H; Pirastu N; Aulchenko YS; de la Chapelle A; Netea-Maier RT; Gough SC; Meyer Zu Schwabedissen H; Frayling TM; Kaufman JM; Linneberg A; Räikkönen K; Smit JW; Kiemeney LA; Rivadeneira F; Uitterlinden AG; Walsh JP; Meisinger C; den Heijer M; Visser TJ; Spector TD; Wilson SG; Völzke H; Cappola A; Toniolo D; Sanna S; Naitza S; Peeters RP
PLoS Genet; 2014 Feb; 10(2):e1004123. PubMed ID: 24586183
[TBL] [Abstract][Full Text] [Related]
4. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression.
Jacobson EM; Huber AK; Akeno N; Sivak M; Li CW; Concepcion E; Ho K; Tomer Y
Genes Immun; 2007 Apr; 8(3):205-14. PubMed ID: 17344890
[TBL] [Abstract][Full Text] [Related]
5. The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of anti-thyroid peroxidase antibody.
Tomari S; Watanabe M; Inoue N; Mizuma T; Yamanaka C; Hidaka Y; Iwatani Y
Endocr J; 2017 Oct; 64(10):1025-1032. PubMed ID: 28845025
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
[TBL] [Abstract][Full Text] [Related]
7. An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts.
Lane LC; Kuś A; Bednarczuk T; Bossowski A; Daroszewski J; Jurecka-Lubieniecka B; Cordell HJ; Pearce SHS; Cheetham T; Mitchell AL
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3277-84. PubMed ID: 32501499
[TBL] [Abstract][Full Text] [Related]
8. Association of established thyroid peroxidase autoantibody (TPOAb) genetic variants with Hashimoto's thyroiditis.
Brčić L; Barić A; Gračan S; Brdar D; Torlak Lovrić V; Vidan N; Zemunik T; Polašek O; Barbalić M; Punda A; Boraska Perica V
Autoimmunity; 2016 Nov; 49(7):480-485. PubMed ID: 27268232
[TBL] [Abstract][Full Text] [Related]
9. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.
Chistiakov DA; Savost'anov KV; Turakulov RI
Mol Genet Metab; 2004 Nov; 83(3):264-70. PubMed ID: 15542398
[TBL] [Abstract][Full Text] [Related]
10. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
[TBL] [Abstract][Full Text] [Related]
11. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
[TBL] [Abstract][Full Text] [Related]
12. Paediatric-onset and adult-onset Graves' disease share multiple genetic risk factors.
Kuś A; Radziszewski M; Glina A; Szymański K; Jurecka-Lubieniecka B; Pawlak-Adamska E; Kula D; Wawrusiewicz-Kurylonek N; Kuś J; Miśkiewicz P; Płoski R; Bolanowski M; Daroszewski J; Jarząb B; Bossowski A; Bednarczuk T
Clin Endocrinol (Oxf); 2019 Feb; 90(2):320-327. PubMed ID: 30358895
[TBL] [Abstract][Full Text] [Related]
13. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
Zeitlin AA; Heward JM; Brand OJ; Newby PR; Franklyn JA; Gough SC; Simmonds MJ
Clin Endocrinol (Oxf); 2006 Sep; 65(3):380-4. PubMed ID: 16918960
[TBL] [Abstract][Full Text] [Related]
14. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study.
Kurylowicz A; Ramos-Lopez E; Bednarczuk T; Badenhoop K
Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):329-35. PubMed ID: 16868893
[TBL] [Abstract][Full Text] [Related]
16. Increased TRAb and/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onset.
Lantz M; Planck T; Asman P; Hallengren B
Exp Clin Endocrinol Diabetes; 2014 Feb; 122(2):113-7. PubMed ID: 24554511
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
Saller B; Hörmann R; Mann K
J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
[TBL] [Abstract][Full Text] [Related]
18. Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.
Yesmin K; Hargreaves C; Newby PR; Brand OJ; Heward JM; Franklyn JA; Gough SC; Simmonds MJ
Clin Endocrinol (Oxf); 2010 Jul; 73(1):119-25. PubMed ID: 20148910
[TBL] [Abstract][Full Text] [Related]
19. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
[TBL] [Abstract][Full Text] [Related]
20. Identification of BACH2 as a susceptibility gene for Graves' disease in the Chinese Han population based on a three-stage genome-wide association study.
Liu W; Wang HN; Gu ZH; Yang SY; Ye XP; Pan CM; Zhao SX; Xue LQ; Xie HJ; Yu SS; Guo CC; Du WH; Liang J; Zhang XM; Yuan GY; Li CG; Su Q; Gao GQ; Song HD;
Hum Genet; 2014 May; 133(5):661-71. PubMed ID: 24346624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
